Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
Clinical trial NCT01194830 · COMPLETED
Trial details
- NCT number
- NCT01194830
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.